Jane is currently a Non-executive Director on the Boards of two FTSE 100 companies: Johnson Matthey plc, a global science company and a leader in sustainable technologies and BAE Systems plc, a multinational defence, security and aerospace company. In February 2020, Jane was appointed to the Board of Directors of the TB Alliance, a not-for-profit organisation, dedicated to the discovery development and delivery of improved medicines for tuberculosis. Additionally, as of 2021, she is ccurrently Chair of Redx Pharma.
With over thirty years' experience in the healthcare industry, Jane was the Global Head at Actelion Pharmaceuticals from June 2017 to December 2019. Prior to this, Jane was Company Group Chair at Janssen EMEA (the pharmaceutical sector of Johnson & Johnson) for over six years, responsible for the entire business across the region.
Jane’s personal business approach is to focus on openness, collaboration, sustainability and accountability. She believes strongly in improving the reputation of the pharmaceutical industry, and through her roles as Chair of the Johnson & Johnson Corporate Citizenship Trust in EMEA and Sponsor of the Janssen Global Pharmaceuticals Sustainability Council, she and her colleagues are working together to implement these values.
Outside of Johnson & Johnson, Jane was also a member of the EFPIA Board, past Chair of the EFPIA Executive Committee and past Chair of the PhRMA Europe Committee.
Jane is a passionate advocate for women in business and STEM education. She sat on the Advisory Board for ‘Your Life’, a UK government-backed program, which ran from 2015 to 2017, and was committed to encouraging young people to study STEM subjects and pursue a career in Science. She was the first female Company Group Chair of Janssen EMEA and is passionate about encouraging more female talent to pursue leadership roles. She was a sponsor of the Johnson & Johnson Women’s Leadership Initiative.
In her time at Johnson & Johnson, Jane has gained in-depth knowledge of oncology, haematology and psychiatry, and significant experience in HIV and HCV. She holds a PhD in Plant Biochemistry from the University College of Wales, Aberystwyth.